rs587781184

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP6BS1BS2

The NM_003172.4(SURF1):​c.54+10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.004 in 1,390,498 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0029 ( 5 hom., cov: 34)
Exomes 𝑓: 0.0041 ( 14 hom. )

Consequence

SURF1
NM_003172.4 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.389

Publications

0 publications found
Variant links:
Genes affected
SURF1 (HGNC:11474): (SURF1 cytochrome c oxidase assembly factor) This gene encodes a protein localized to the inner mitochondrial membrane and thought to be involved in the biogenesis of the cytochrome c oxidase complex. The protein is a member of the SURF1 family, which includes the related yeast protein SHY1 and rickettsial protein RP733. The gene is located in the surfeit gene cluster, a group of very tightly linked genes that do not share sequence similarity, where it shares a bidirectional promoter with SURF2 on the opposite strand. Defects in this gene are a cause of Leigh syndrome, a severe neurological disorder that is commonly associated with systemic cytochrome c oxidase deficiency. [provided by RefSeq, Jul 2008]
SURF2 (HGNC:11475): (surfeit 2) This gene shares a bidirectional promoter with surfeit 1 (SURF1; GeneID: 6834), which is located on the opposite strand. It encodes a conserved protein that is expressed in a variety of tissues. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 9-133356390-C-T is Benign according to our data. Variant chr9-133356390-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 139379.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00285 (433/151860) while in subpopulation SAS AF = 0.00455 (22/4834). AF 95% confidence interval is 0.00383. There are 5 homozygotes in GnomAd4. There are 206 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SURF1NM_003172.4 linkc.54+10G>A intron_variant Intron 1 of 8 ENST00000371974.8 NP_003163.1 Q15526-1E5KRX5
SURF1NM_001280787.1 linkc.-222+10G>A intron_variant Intron 1 of 7 NP_001267716.1 Q15526A0A087WYS9
SURF2NM_017503.5 linkc.-203C>T upstream_gene_variant ENST00000371964.5 NP_059973.4 Q15527
SURF2NM_001278928.2 linkc.-203C>T upstream_gene_variant NP_001265857.1 Q15527

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SURF1ENST00000371974.8 linkc.54+10G>A intron_variant Intron 1 of 8 1 NM_003172.4 ENSP00000361042.3 Q15526-1
SURF2ENST00000371964.5 linkc.-203C>T upstream_gene_variant 1 NM_017503.5 ENSP00000361032.4 Q15527

Frequencies

GnomAD3 genomes
AF:
0.00285
AC:
433
AN:
151754
Hom.:
5
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000556
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00210
Gnomad ASJ
AF:
0.0164
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00455
Gnomad FIN
AF:
0.000191
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.00423
Gnomad OTH
AF:
0.00336
GnomAD2 exomes
AF:
0.00535
AC:
127
AN:
23718
AF XY:
0.00554
show subpopulations
Gnomad AFR exome
AF:
0.00455
Gnomad AMR exome
AF:
0.00319
Gnomad ASJ exome
AF:
0.0213
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00499
Gnomad OTH exome
AF:
0.00802
GnomAD4 exome
AF:
0.00414
AC:
5127
AN:
1238638
Hom.:
14
Cov.:
36
AF XY:
0.00411
AC XY:
2493
AN XY:
607026
show subpopulations
African (AFR)
AF:
0.000451
AC:
11
AN:
24364
American (AMR)
AF:
0.00254
AC:
41
AN:
16130
Ashkenazi Jewish (ASJ)
AF:
0.0180
AC:
341
AN:
18996
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27132
South Asian (SAS)
AF:
0.00319
AC:
188
AN:
59020
European-Finnish (FIN)
AF:
0.000198
AC:
6
AN:
30232
Middle Eastern (MID)
AF:
0.00876
AC:
31
AN:
3538
European-Non Finnish (NFE)
AF:
0.00427
AC:
4307
AN:
1008314
Other (OTH)
AF:
0.00397
AC:
202
AN:
50912
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
274
547
821
1094
1368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00285
AC:
433
AN:
151860
Hom.:
5
Cov.:
34
AF XY:
0.00277
AC XY:
206
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.000554
AC:
23
AN:
41488
American (AMR)
AF:
0.00210
AC:
32
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.0164
AC:
57
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00455
AC:
22
AN:
4834
European-Finnish (FIN)
AF:
0.000191
AC:
2
AN:
10462
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.00423
AC:
287
AN:
67880
Other (OTH)
AF:
0.00332
AC:
7
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00420
Hom.:
0
Bravo
AF:
0.00295

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SURF1: BS2 -

Oct 21, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 02, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Leigh syndrome Uncertain:1Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Apr 01, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
13
DANN
Benign
0.87
PhyloP100
0.39
PromoterAI
-0.084
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.67
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.67
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587598397; hg19: chr9-136223266; API